二线治疗 英语是什么意思 - 英语翻译

• second-line treatment
• second-line therapies
• second-line therapy

在 中文 中使用 二线治疗 的示例及其翻译为 英语

一旦癌症变得抗性，只有免疫治疗被批准为二线治疗。
Once cancers become resistant, only checkpoint immunotherapy is approved as second-line treatment.

尚未确定对HIV-2的初始和二线治疗方案。
Choice of initial and/or second-line therapy for HIV-2 has not yet been defined.

二线治疗：.
Second Line Treatment:.

最新指南为一线和二线治疗方案提出了新的建议。
The new guidelines issue new recommendations for first and second line treatments.

但是需要二线治疗正在迅速增长。
But the need for second-line treatment is now growing rapidly.

控制头虱和疥疮的人类健康二线治疗药物.
Human health pharmaceutical for control of head lice and scabies as second lien treatment.

但二线治疗方案具有局限性，所推荐使用的药物不是总能得到。
However second-line treatment options are limited and recommended medicines are not always available.

但二线治疗方案具有局限性，且需要用价格昂贵且有毒性的药物进行长期化疗（长达两年治疗时间）。
However, second-line treatment options are limited and require extensive chemotherapy(up to 2 years of treatment) with medicines that are expensive and toxic.

药物将被限制在一线和二线治疗所用，并限制专门药物的使用。
Drugs will be restricted to first- and second-line therapies, with limitations on the use of specialty drugs.

目前该方法被用作二线治疗，以减轻不能改善血液稀释剂的人的疼痛和肿胀。
The procedure is currently used as a second-line treatment to alleviate pain and swelling in people who do not improve on blood thinners.

(e)在扩大一线抗逆转录病毒治疗的同时，各国还应为未来二线治疗需求的增加作出规划。
(e) While bringing first-line antiretroviral treatment to scale, countries should plan for future increased demand for second-line therapies.

二线治疗也许可以提高晚期胰腺癌（APC）的生存率，但是获益患者的最佳预测方法尚未确定。
Second-line therapy may improve survival in advanced pancreatic cancer(APC), although the best way to predict which patients will benefit is not established.

尽管当今有很多肾脏癌患者选择，但大多数用于一线和二线治疗。
Although there are many options for patients with kidney cancer today, most are intended for first- and second-line therapy.

我们的新的研究表明，这将是值得调查p110α抑制剂是否可以作为二线治疗。
Our new study suggests that it would be worth investigating whether p110α inhibitors could be used as a second-line therapy.

Dolutegravir是世界卫生组织(WHO)推荐的首选一线和二线治疗药物，已成为高收入国家的首选药物。
Dolutegravir is the preferred first-line and second-line treatment recommended by the World Health Organization, and already the drug of choice in high-income countries.

然而，二线治疗选择是有限制的和所推荐药物未必可以得到。
However second-line treatment options are limited and recommended medicines may not be always available.

但二线治疗方案具有局限性，且需要用价格昂贵且有毒性的药物进行长时间化疗（长达两年治疗时间）。
Second-line treatment options are limited and require extensive chemotherapy(up to two years of treatment) with medicines that are expensive and toxic.

在二线治疗中使用药物的成本比在第一线组合使用的药物等等。
Medicines used in second-line treatment cost much more than drugs used in first-line combinations.

患者还经常对靶向治疗产生抗性，并且一旦抗性产生，就需要进行二线治疗。
Patients also often develop resistance to targeted therapies and require a second-line treatment once resistance develops.

一旦癌症成为抗药性，只有检查点免疫疗法被批准为二线治疗。
Once cancers become resistant, only checkpoint immunotherapy is approved as second-line treatment.

例如，从糖尿病二线治疗的广泛变化中，我们可以尝试来确定哪些是更有效的。
For example, from the wide variation in second-line treatments for diabetes, we can attempt to identify those that are more effective.

DCVAC/OvCa将卵巢癌二线治疗的死亡风险降低了62％。
DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62%.

二线治疗方案为AZT或TDF+3TC+LPV/r方案。
For second-line therapy, AZT+ 3TC+ LPV/r or TDF+ 3TC/FTC+ LPV/r were administered.

年，只有五分之一新近获得二线治疗服务资格的人能够获得此项服务。
In 2015, only one in five of the people newly eligible for second-line treatment were able to access it.

同时，先前完成的CYRAMZA临床3期研究结果也支持该药物用于胃癌和结直肠癌二线治疗的批准。
Results of previously completed Phase 3 studies of CYRAMZA have also supported approvals in second-line gastric and colorectal cancer.

美国食品和药物管理局(FDA)于2015年批准欧狄沃(Opdivo)作为第一种免疫治疗药物和二线治疗晚期非小细胞肺癌(NSCLC)。
The U.S. Food and Drug Administration(FDA) in 2015 approved Opdivo as the first immunotherapy drug and second-line treatment for advanced non-small cell lung cancer(NSCLC).

加强所有联合国所属医疗设施诊断能力的工作将于2013/14年度完成，药品将限于一线和二线治疗使用，特效药也将限制使用。
The enhancement of the diagnostic capabilities of all United Nations-owned medical facilities will be completed in 2013/14, and drugs will be restricted to first- and second-line therapies, with limitations on the use of speciality drugs.

加强联合国所属医疗设施的诊断能力将继续完善提供的服务，药品将限于一线和二线治疗使用，特种药也将限制使用。
The enhanced diagnostic capabilities of United Nations-owned medical facilities will continue to improve service delivery and drugs will be restricted to first- and second-line therapies, with limitations on specialty drugs.